Conhecimento dos alunos de medicina sobre papilomavírus humano (HPV), câncer cervical e vacinação contra HPV

rbem Revista Brasileira de Educação Médica Rev. bras. educ. med. 0100-5502 1981-5271 Associação Brasileira de Educação Médica Resumo: Introdução: Há ainda, entre os estudantes de Medicina, muitas dúvidas com relação ao papilomavírus humano (HPV) e à vacina contra esse vírus. Objetivo: Este estudo teve como objetivo avaliar a compreensão dos estudantes de Medicina da Universidade de Brasília acerca do HPV, da sua relação com o câncer e da vacina contra o vírus. Método: Foi realizado um estudo transversal por meio da aplicação de um questionário teste sobre os temas. A avaliação envolveu 379 respondentes, o que representava 72,7% dos 521 alunos do primeiro ao sexto ano matriculados no segundo semestre de 2017. As análises estatísticas incluíram diferenças entre médias e proporções, medidas de tamanho de efeito e a correlação entre os indicadores identificados. O estudo foi aprovado pelo Comitê de Ética em Pesquisa em Seres Humanos da Faculdade de Medicina (1,989,835). Resultado: A pontuação de conhecimento de 50 itens aumentou progressivamente com o ano do curso médico (r = 0,706, p <0,001) e foi maior entre os participantes sexualmente ativos em comparação com os celibatários (t = 3,26, df = 275, p = 0,001, d = 0,37), e entre os participantes com renda familiar mais alta em comparação com aqueles com renda mais baixa (t = 2,91, df = 366, p = 0,004, d = 0,35). Nenhuma diferença significativa de pontuação foi observada entre os participantes agrupados por gênero, comportamento sexual ou estado de vacinação contra o HPV. Além disso, sexo (feminino; OR = 6,5, p <0,001), faixa etária (<24 anos; OR = 3,3, p = 0,001) e sexualidade (ativo; OR = 2,7, p = 0,002), mas não o conhecimento geral, foram preditores do desejo de vacinação entre 297 alunos não vacinados. Conclusão: O estudo revelou uma forte correlação entre o conhecimento relacionado ao HPV dos estudantes de Medicina e o ano de estudo, e pontuações significativamente mais altas entre os respondentes sexualmente ativos e de renda superior, mas não houve nenhuma diferença essencial entre homens e mulheres ou entre alunos vacinados e não vacinados. Entre estes últimos, gênero, idade, sexualidade, e não o conhecimento foram os melhores preditores do desejo de vacinação. Os achados sugerem a necessidade de aperfeiçoamento em programas de triagem e vacinação para HPV e nas estratégias educacionais referentes às doenças relacionadas ao vírus. INTRODUCTION Cervical cancer is a public health problem, since it is the fourth most common type of cancer and the fourth cause of death due to the occurrence of neoplasia in the female population worldwide, the vast majority occurring in developing countries1. As an example, 16,590 new cases of cervical cancer per year are expected in 2020-22 in Brazil, according to data from National Cancer Institute, with an estimated average risk of 15.43 new cases per 100,000 women2. Among the known risk factors for developing cervical cancer, high-risk Human Papillomavirus (HPV) infection ranks a prominent place3),(4. Experts estimate that most sexually active men and women will have contact with the virus at some point in their lives. However, spontaneous regression of the infection occurs in more than 80% of the cases5. Infection persistence is necessary for the onset of neoplasia and it has an estimated 85-99% prevalence in cervical cancer cases6. The Brazilian Health System introduced the HPV immunization program in 2014. Currently, in addition to other specific indications, the quadrivalent HPV vaccine is available in the Unified Health System (SUS) for females aged nine to 14 years and males aged 11 to 14 years in a two-dose schedule with a 6-month interval7. The strong correlation between oncogenic HPV infection and cervical cancer makes vaccination an essential public health prevention tool8. However, although clinical trials established the vaccine’s safety and efficacy9, the adherence to vaccination falls short of conventional standards. In 2017, the cumulative vaccination coverage of the HPV vaccine in Brazilian girls aged nine to 14 years was 82.6% for the first dose and 52.8% for the second dose. Among boys aged 12 and 13, only 43.8% of them had received the first dose7. Solid knowledge and a positive attitude towards the vaccine among medical students indicate a favorable outlook for their future actions as health service providers in adhering to screening and vaccination programs10. For example, in the United States, Afonso et al.11, using a 15-item survey, highlighted that fully vaccinated compared to non-vaccinated respondents had a better understanding and more positive attitudes. However, in Scotland, McCusker et al.12 revealed the lack of knowledge of first-year students about the extent of protection against cervical cancer provided by the vaccine, and in China, Wen et al.13 indicated poor knowledge of HPV and HPV vaccination among medical students. Therefore, the study aimed to assess the medical students’ grasp of knowledge related to HPV, its relationship with cervical cancer, and the vaccine against the virus according to their profiles, level of study, and vaccination status. It was assumed that a significant relationship would be found between the students’ knowledge and their level of study and demographic profiles. METHODS Participants In a cross-sectional study, students attending from the first to the sixth years of medical school at the University of Brasilia answered a survey devised as a test questionnaire. The survey test included questions about cervical cancer, HPV, and the vaccine against HPV, with possible responses including, Yes, No, and I Don’t Know. The development of the instrument benefited extensively from published examples in the literature8),(14)-(16. The Ethics Committee in Research on Human Beings of the School of Medicine approved the study (1,989,835). The eligibility criteria comprised attendance in the second semester of 2017 by students aged at least 18 years old from each period (semester) of the undergraduate medical school. As a rule, students were contacted during class time. As reported elsewhere, 392 students returned the survey tool and the signed consent form, but 13 cases were excluded from the study (six because the respondents omitted information about HPV vaccination and seven because they were younger than 18 years old)17. Therefore, the analyses included the questionnaires from 379 students, 72.7% of 521 students enrolled in the second half of 2017. Therefore, the estimated sample size for a satisfactory response rate (95% confidence level, 3% interval) comprised 350 students. Procedures We grouped the participants according to gender, monthly family income, sexuality profile, vaccination status, and year at medical school. The family income, established according to the number of minimum wages earned per month upheld two groups: a higher-income (≥ five minimum wages per month) and a lower-income (< five minimum wages per month) group. Regarding the vaccination status, three groups were identified: one of vaccinated participants, a second comprising those who were not vaccinated but who wished the immunization and the third included the students who did not receive nor wanted the vaccine. As for the sexuality, celibates constituted one group and sexually-active participants the other. Finally, the study level separated students attending years 1 to 4 from years 5 to 6 (which includes the internship). This last criterion included students before and after approval in Gynecology and Obstetrics courses (held in the 8th semester of the medical program). A preliminary review of the responses to 57 knowledge items of the questionnaire excluded seven questions with a problematic discrimination index and item-total score correlation. For the remaining 50 questions, the reliability analysis showed acceptable internal consistency (Cronbach’s alpha = 0.87), even if a factor analysis detected multiple components in the students’ responses. Thus, a sum of correct answers was calculated for that set of items. Henceforth, the resulting total score, expressed as a percentage, was named the K-test score. Statistical Analysis In addition to means, frequencies, and proportions, the statistical analyses included t-tests for differences, Pearson’s correlations, analyses of contingency and one-way ANOVA, all for K-test scores between the student groups. Effect sizes and confidence intervals (CI) were calculated, and p<0.05 (two-tailed) was adopted for statistical significance. The SPSS software, version 17, was used in the statistical analysis. RESULTS The mean age of the 379 participants was 21.8 ± 3.1 years and, among them, 82 (21.6%) were aged 24 or older. Of the total, 218 (57.5%) were males, and among 368 respondents, 279 (75.8%) reported a monthly family income equal to or greater than five minimum wages. As for the sexuality profile, of the 372 respondents (who informed about recent sexual partners), 218 (58.6%) used barrier contraceptive methods, 97 (26.1%) declared themselves to be celibates, 93 (25.0%) reported two or more partners, and 44 (11.8%) admitted sexual initiation before 16 years of age. Regarding the participants’ HPV-vaccination status, 80 (21.1%) reported being vaccinated, while 215 (56.7%) had not received the vaccine but wished to, and 84 (22.2%) had neither received it nor wanted to. However, the rates of vaccination were significantly different between males (9.2%) and females (37.3%); the odds ratio for female immunization was 5.88 (95% CI 3.36, 10.29); Fisher’s exact test < 0.0001. The K-test average score for the 379 participants was 60.6% (SD= 15.4%). The correlation between the student’s score and the year at the medical school was strong (r= .706, p<0.001). In addition, students attending years 5 to 6 had a much higher score than those attending years 1 to 4 (t = 19.0, df = 262.6, p <0.0001). Figure 1 shows the upward trend of the K-test results for students from year 1 to year 6 and highlights the increase in the growth rate from year 4 to year 5, in parallel to K-test topics’ formal learning in the 8th semester of the Gynecology-Obstetrics courses. Figure 1 The first-to-sixth year medical students’ knowledge of HPV-related topics (K-test) Sexually-active students had higher K-test scores than celibate students (t = 3.26, df = 275, p = 0.001). Likewise, students who reported higher family income had higher scores than those who reported lower income (t = 2.91, df = 366, p = 0.004). On the other hand, there was no significant difference between male and female students regarding the K-test scores (t = 0.47, df = 377, p = 0.638). The data depicted in Table 1 show the much larger effect size (Cohen’s d) of the study level when compared to the other conditions. Table 1 Differences (by decreasing effect size) in K-test scores between medical students grouped according to their level of studies, sexuality, monthly family income, and gender. Students’ Conditions Groups N K-test scores Difference (95% CI) Cohen’s d Mean (SD) Level of study Years 5-6 108 76.6 (9.3) 22.3 (20.1, 24.7) 1.91 Years 1-4 271 54.3 (12.5) Sexuality Sexually Active 267 62.2 (14.7) 5.6 (2.2, 9.0) 0.37 Celibate 110 56.6 (15.5) Monthly family income >US$300 279 62.0 (15.3) 5.4 (1.8, 9.1) 0.35 <US$300 89 56.6 (15.2) Gender Male 218 60.3 (15.6) -0.08 (-3.9, 2.4) 0.05 Female 161 61.1 (15.2) K-test: knowledge (%) of items related to human papillomavirus and associated conditions. CI: confidence interval. Cohen’s d: effect size. Using one-way ANOVA procedures, no significant differences in K-test scores were found among respondents, grouped according to sexual behavior (F = 0.54, df = 2; 367, p = 0.593). Similarly, no significant differences emerged in K test scores between participants grouped according to HPV vaccination status (F = 2.85, df = 2; 376, p = 0.059). Nevertheless, the scores increased according to adherence status: from 58.3 (not vaccinated, nor willing to), to 60.3 (not vaccinated, but willing to) to 64.0 (vaccinated). According to the students’ level of study, a distinctive upward trend in the percentage of correct answers was observed for most K-test items. Table 2 shows the association (for 13 selected items) between each item answer (correct or incorrect) and the level of study (1st to 4th year vs. 5th to 6th year). Again, significant associations appeared for both underperforming and high-performing items. However, in contrast to information-based responses, responses to attitude-related questions (e.g., vaccination and multiple sexual partners) were not associated with the study level. Table 2 Measures of association (Odds Ratio) between the study levels and correct responses to survey items on the medical students’ knowledge about HPV-related topics. Survey items (ordered by increasing percentage of overall correct answers) Correct/ Incorrect Response Study Levels Odds Ratio (95% CI) Fisher’s Exact test Year 1-4 Year 5-6 HPV is a cause of infertility C 7 34 17.2 (7.3,40.5) <0.0001 I 263 74 The preventive Pap smear can detect HPV infection C 16 32 6.7 (3.5,12.8) <0.0001 I 254 76 HPV causes genital herpes C 68 77 7.4 (4.5,12.2) <0.0001 I 202 31 HPV vaccine is available to both boys and girls C 95 90 9.2 (5.2,16.2) <0.0001 I 175 18 HPV can be transmitted by sitting on a toilet seat C 109 95 10.8 (5.8,20.2) <0.0001 I 161 13 HPV may cause anal and oral cancers C 151 85 2.9 (1.7,4.9) <0.0001 I 119 23 Early sex is a risk factor for cervical cancer C 164 99 7.2 (3.5,14.8) <0.0001 I 107 9 HPV vaccination is inadequate for males C 186 95 3.3 (1.7,6.2) 0.0001 I 84 13 Most HPV infections are symptomatic C 183 101 6.9 (3.1,15.4) <0.0001 I 87 7 HPV vaccination promotes sexual promiscuity C 205 85 1.2 (0.7,2.0) 0.5922 I 66 23 The efficacy of HPV vaccination is higher before sexual initiation C 210 101 4.1 (1.8,9.3) 0.0003 I 60 7 Multiple sexual partners are a risk factor for cervical cancer C 215 107 27.9 (3.8,204) <0.0001 I 56 1 The HPV vaccine is available in the public health services C 246 108 10.5 (1.4,78.9) 0.0047 I 24 1 HPV: human papillomavirus. C: correct. I: incorrect. CI: confidence interval. Only three of the 50 K-test items (36, 49, and 50) showed a significant association with HPV vaccine acceptance among the 297 unvaccinated students. Table 3 shows the association between each response item (correct or incorrect) and acceptance of vaccination (unwilling vs. wishing). However, in an unplanned binary logistic regression analysis, four variables were significant predictors of vaccine desirability: gender (female; OR = 6.5, p <0.001), age group (<24 years; OR = 3.3, p = 0.001), sexuality (active; OR = 2.7, p = 0.002) and item 36 (incorrect; OR = 2.0, p = 0.029). In the regression model summary, Nagelkerke R Square was equal to 0.227 (meaning that those four items represent 22.7% of the variability in HPV vaccination desire). Table 3 Measures of association (Odds Ratio) between medical students’ responses to items about knowledge on HPV-related topics and their acceptance of the HPV vaccine Survey Items (number) Correct, Incorrect Response Acceptance of Vaccine Odds Ratio Fisher’s Exact Test Not Wishing Wishing (95% CI) 49. The HPV vaccine is available in the public health services C 73 205 3.1 (1.3,7.6) 0.0137 I 11 10 50. The HPV vaccine is available to both boys and girls C 31 110 1.8 (1.1,3.0) 0.0289 I 53 105 36. Most HPV infections are symptomatic C 55 167 1.8 (1.1,3.2) 0.0390 I 29 48 11. Multiple sexual partners are a risk factor for cervical cancer C 65 185 1.8 (.95,3.4) 0.0822 I 19 30 HPV: human papillomavirus. C: correct. I: incorrect. CI: confidence interval. Concerning some specific items, 81% of participants satisfactorily recognized various risk factors for cervical carcinoma, and only 3.7% were unaware of the Pap smear test. Also, 94.7% knew that HPV could infect men and women, and more than 60% knew the causal association of HPV with various cancer sites. Furthermore, most of the students (73.6%) knew about the protection against cervical cancer offered by the HPV vaccine, but 23.5% of the participants suspected that vaccination could increase sexual promiscuity. Besides, 93.7% of students were aware of the availability of the HPV vaccine in public health services, but only 48.9% of them knew that the vaccine is available to both sexes. DISCUSSION As expected, a significant association emerged between the participants’ knowledge of HPV-related topics (K-test score) and level of medical study, a finding similar to what was reported by other authors18)-(21. Notably, the increase in the K-test score growth rate between the fourth and fifth years was associated with the approval in the Ob-Gyn courses in the 8th semester of the medical school. The robust odds ratios observed for 13 items in Table 2 corroborate the influence of that learning experience. Also, significant differences in K-test scores emerged for the income and sexual activity groups. Regarding the family income, the means of correct answers were significantly lower in the lower-income group. Thus, income can be a potential influencer in terms of the students’ access and incorporation/ understanding of available information. As for sexual activity, it is interesting to note that celibate students scored lower on the knowledge of HPV-related topics, perhaps because it was not their concern at that time. A recent study found no association between receiving the HPV vaccine and sexual behavior, condom, and contraceptive method use22. No significant gender difference turned up in the K-test score, a finding similar to that reported by Liu et al.10. Notably, the HPV vaccination rate was significantly higher among women. However, the three-year delay in the inclusion of boys in the national HPV immunization program7) may partly explain the lower adherence to the vaccine by men. Additionally, the vaccination campaigns focused on cervical cancer prevention, not on penis, anal, and oropharynx cancer prevention21. Several factors may explain the inconclusive differences in K-test scores concerning students’ vaccination status. First, the K-test score is a global measure of declarative HPV-related knowledge, and vaccination seems to be associated with specific information. Second, the immunization timing preceded the appraisal of knowledge in this study, given the students’ age profile. Third, we found evidence that personal advice (mostly parental) was a more powerful source of influence among those participants17. The finding that corroborates this line of reasoning was that only three information items were related to the acceptance (desire) of the HPV vaccine. Of course, health professionals’ attitudes, the standard of public health information, and various individual, social, and cultural factors may better explain acceptance and adherence to vaccination. Overall, the data from the present study showed that most students satisfactorily recognized the risk factors for cervical carcinoma; 94.7% knew that HPV could infect both sexes, and over 60% knew the association between HPV and several cancer sites. However, Deriemaeker et al.16 found that despite the high HPV vaccination rate in Belgium, 46% of medical students and 26% of students from other courses knew that HPV could cause cancer in the anogenital region (anus and penis). In another study, only 44% of the medical students surveyed at a university in India correctly answered that HPV could cause vulva, penis, oral and vaginal cancer23. Additionally, surveys from six Chinese universities found that only 14.4% of medical students who answered a questionnaire believed that persistent HPV infection could cause cervical cancer, and 48.8% of them that vaccination could prevent cervical cancer8. In the present study, most participants (73.6%) were aware of the protection against cervical cancer offered by the HPV vaccine. Notably, almost a quarter of the participants admitted the influence of HPV vaccination on sexual promiscuity. This issue has been a concern of parents regarding girls’ immunization, mainly about the risk of stimulating early sexual intercourse24. A study conducted in 2009 showed that, for those people, sexuality should be discussed before vaccination, since many believed that campaigns could increase risky sexual behavior25. However, a study carried out in England did not observe differences regarding sexual behavior between groups of vaccinated and non-vaccinated adolescents26. Also, a Scandinavian study found that the mean age at the first sexual intercourse was not significantly different between women who had been vaccinated against HPV before or after the onset of sexual activity and the number of sexual partners27. The present study has limitations. Because of its cross-sectional design, it not possible to establish a cause-effect relationship between the knowledge about HPV-related topics and the demographics, sexuality profile, and vaccination status of the participants. The test used assesses just a sample of declarative knowledge and not a deep understanding of HPV issues. Furthermore, since the study included medical students from a single school of medicine, it is impossible to generalize the findings to other schools or students. Nevertheless, the results represent the student-body’s grasp of HPV-related topics, and some findings show compelling associations. For example, we found it interesting that several students asked for more information about some test issues after the questionnaire application, even those already covered in the medical curriculum. The findings suggest a need for improvement in screening and vaccination programs and educational strategies regarding HPV-related diseases. Better instructional strategies may help future physicians to instruct different social groups and to clarify their patients’ doubts about those topics. CONCLUSION The study revealed a strong correlation of medical students’ HPV-related knowledge with the year attended at the medical school and significantly higher scores among sexually active and higher-income respondents, but no essential difference between males and females or between vaccinated and unvaccinated students. Altogether, the results indicate that the medical students’ attributes and external backgrounds have a more considerable influence on the HPV-vaccination status than the educational environment and formal training. REFERENCES 1 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2018 68 6 394 424 2 2. Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Incidência de Câncer no Brasil. Estimativa para 2020 [access in 04 feb 2020]. Available from: Available from: https://www.inca.gov.br/estimativa/2020.pdf . Brasil Instituto Nacional de Câncer José Alencar Gomes da Silva Incidência de Câncer no Brasil. Estimativa para 2020 04 feb 2020 Available from: https://www.inca.gov.br/estimativa/2020.pdf 3 3. Hausen HZ. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384(2):260-5. Hausen HZ Papillomaviruses in the causation of human cancers - a brief historical account Virology 2009 384 2 260 265 4 4. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. Muñoz N Bosch FX de Sanjosé S Herrero R Castellsagué X Shah KV International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 2003 348 6 518 527 5 5. Wong LP. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis. 2009;13:85-93. Wong LP Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups J Low Genit Tract Dis 2009 13 85 93 6 6. De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56. De Sanjose S Quint WG Alemany L Geraets DT Klaustermeier JE Lloveras B Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 2010 11 11 1048 1056 7 7. Brasil. Ministério da Saúde. [access in 04 feb 2020].Available from: Available from: http://portalms.saude.gov.br/images/pdf/2018/marco/14/Informe-T--clinico-HPV-MENINGITE.pdf . Brasil Ministério da Saúde 04 feb 2020 Available from: http://portalms.saude.gov.br/images/pdf/2018/marco/14/Informe-T--clinico-HPV-MENINGITE.pdf 8 8. Pan XF, Zhao ZM, Sun J, Chen F, Wen QL, Liu K, et al. Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education. PLoS One. 2014;9(10):e110353. Pan XF Zhao ZM Sun J Chen F Wen QL Liu K Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education PLoS One 2014 9 10 e110353 9 9. Agorastos T, Chatzigeorgiou K, Brotherton JM, Garland SM. Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far. Vaccine. 2009;27(52):7270-81. Agorastos T Chatzigeorgiou K Brotherton JM Garland SM Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far Vaccine 2009 27 52 7270 7281 10 10. Liu A, Ho FK, Chan LK, Ng JY, Li SL, Chan GC, et al. Chinese medical students’ knowledge, attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine. J Paediatr Child Health. 2018;54(3):302-10. Liu A Ho FK Chan LK Ng JY Li SL Chan GC Chinese medical students’ knowledge, attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine J Paediatr Child Health 2018 54 3 302 310 11 11. Afonso NM, Kavanagh MJ, Swanberg SM, Schulte JM, Wunderlich T, Lucia VC. Will they lead by example? Assessment of vaccination rates and attitudes to human papillomavirus in millennial medical students. BMC Public Health. 2017;17(1):35. Afonso NM Kavanagh MJ Swanberg SM Schulte JM Wunderlich T Lucia VC Will they lead by example? Assessment of vaccination rates and attitudes to human papillomavirus in millennial medical students BMC Public Health 2017 17 1 35 35 12 12. McCusker SM, Macqueen I, Lough G, Macdonald AI, Campbell C, Graham SV. Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC Public Health . 2013;13:264. McCusker SM Macqueen I Lough G Macdonald AI Campbell C Graham SV Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland BMC Public Health 2013 13 264 264 13 13. Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li SQ, et al. Knowledge of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccine and its correlates among medical students in Southwest China: a multi-center cross-sectional survey. Asian Pac J Cancer Prev. 2014;15(14):5773-9. Wen Y Pan XF Zhao ZM Chen F Fu CJ Li SQ Knowledge of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccine and its correlates among medical students in Southwest China: a multi-center cross-sectional survey Asian Pac J Cancer Prev 2014 15 14 5773 5779 14 14. Al-Shaikh GK, Almussaed EM, Fayed AA, Khan FH, Syed SB, Al-Tamimi TN, et al. Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papillomavirus vaccine. Saudi Med J. 2014;35(10):1223-30. Al-Shaikh GK Almussaed EM Fayed AA Khan FH Syed SB Al-Tamimi TN Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papillomavirus vaccine Saudi Med J 2014 35 10 1223 1230 15 15. Ghojazadeh M, Azar ZF, Saleh P, Naghavi-Behzad M, Azar NG. Knowledge and attitude of Iranian University students toward human papillomavirus. Asian Pac J Cancer Prev . 2012;13(12):6115-9. Ghojazadeh M Azar ZF Saleh P Naghavi-Behzad M Azar NG Knowledge and attitude of Iranian University students toward human papillomavirus Asian Pac J Cancer Prev 2012 13 12 6115 6119 16 16. Deriemaeker H, Michielsen D, Reichman G, Devroey D, Cammu H. Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students. CentEuropean J Urol. 2014;67(4):410-7. Deriemaeker H Michielsen D Reichman G Devroey D Cammu H Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students CentEuropean J Urol 2014 67 4 410 417 17 17. Wanderley MS, Sobral, DT, Levino LA, Marques LA, Feijó MS, Aragão NRC. Students’ HPV vaccination rates are associated with demographics, sexuality, and source of advice but not level of study in medical school. Rev Inst Med Trop São Paulo. 2019;61:e70. Wanderley MS Sobral DT Levino LA Marques LA Feijó MS Aragão NRC Students’ HPV vaccination rates are associated with demographics, sexuality, and source of advice but not level of study in medical school Rev Inst Med Trop São Paulo 2019 61 e70 18 18. Borlu A, Gunay O, Balci E, Sagiroglu M. Knowledge and Attitudes of Medical and Non-Medical Turkish University Students about Cervical Cancer and HPV Vaccination. Asian Pac J Cancer Prev . 2016;17(1):299-303. Borlu A Gunay O Balci E Sagiroglu M Knowledge and Attitudes of Medical and Non-Medical Turkish University Students about Cervical Cancer and HPV Vaccination Asian Pac J Cancer Prev 2016 17 1 299 303 19 19. Wong LP, Sam IC. Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol, 2010;148:90-5. Wong LP Sam IC Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer Eur J Obstet Gynecol Reprod Biol 2010 148 90 95 20 20. Swarnapriya K, Kavitha D, Reddy GMM. Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross-Sectional Study. Asian Pac J Cancer Prev 2015;16(18):8473-7. Swarnapriya K Kavitha D Reddy GMM Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross-Sectional Study Asian Pac J Cancer Prev 2015 16 18 8473 8477 21 21. Yam PW, Lam PL, Chan TK, Chau KW, Hsu ML, Lim YM, et al. A cross-sectional study on knowledge, attitude and practice related to Human Papillomavirus vaccination for cervical cancer prevention between medical and non-medical students in Hong Kong, Asian Pac J Cancer Prev . 2017;18:1689-95. Yam PW Lam PL Chan TK Chau KW Hsu ML Lim YM A cross-sectional study on knowledge, attitude and practice related to Human Papillomavirus vaccination for cervical cancer prevention between medical and non-medical students in Hong Kong Asian Pac J Cancer Prev 2017 18 1689 1695 22 22. Vatopoulou A, Papanikolaou A, Diavatis S, Goulis DG. Human Papilloma Virus Vaccination and Attitudes Towards Contraception: A Cross-Sectional Study. Eur J Contracept Reprod Health Care. 2019;24(3):182-7. Vatopoulou A Papanikolaou A Diavatis S Goulis DG Human Papilloma Virus Vaccination and Attitudes Towards Contraception: A Cross-Sectional Study Eur J Contracept Reprod Health Care 2019 24 3 182 187 23 23. Mehta S, Rajaram S, Goel G, Goel N. Awareness about human papillomavirus and its vaccine among medical students. Indian J Community Med. 2013;38:92-4. Mehta S Rajaram S Goel G Goel N Awareness about human papillomavirus and its vaccine among medical students Indian J Community Med 2013 38 92 94 24 24. Perez S, Zimet GD, Tatar O, Stupiansky NW, Fisher WA, Rosberger Z. Human Papillomavirus Vaccines: Successes and Future Challenges. Drugs 2018;78(14):1385-96. Perez S Zimet GD Tatar O Stupiansky NW Fisher WA Rosberger Z Human Papillomavirus Vaccines: Successes and Future Challenges Drugs 2018 78 14 1385 1396 25 25. Ragin CC, Edwards RP, Jones J, Thurman NE, Hagan KL, Jones EA, et al. Knowledge about human papillomavirus and the HPV vaccine - a survey of the general population. Infect Agent Cancer. 2009;4(suppl 1):S10. Ragin CC Edwards RP Jones J Thurman NE Hagan KL Jones EA Knowledge about human papillomavirus and the HPV vaccine - a survey of the general population Infect Agent Cancer 2009 4 suppl 1 S10 26 26. Forster AS, Marlow LAV, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine .2012;30(33):4939-44. Forster AS Marlow LAV Stephenson J Wardle J Waller J Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England Vaccine 2012 30 33 4939 4944 27 27. Hansen T, Kjær K, Arnheim-Dahlström L, Liaw L, Jensen E, Thomsen T, et al. Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women. Vaccine . 2014;32(39):4945-53. Hansen T Kjær K Arnheim-Dahlström L Liaw L Jensen E Thomsen T Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women Vaccine 2014 32 39 4945 4953 2 Evaluated by double blind review process. SOURCES OF FUNDING The authors declare no sources of funding.